Abstract Coronavirus disease in 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is pandemic worldwide SARS-CoV-2 IgM/IgG tests have been developed around the world for diagnosis and management of COVID-19 patients, and sero-epidemiological surveillance1 This article is protected by copyright All rights reserved
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19